These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Multiparameter flow cytometry in the diagnosis and management of acute leukemia. Peters JM; Ansari MQ Arch Pathol Lab Med; 2011 Jan; 135(1):44-54. PubMed ID: 21204710 [TBL] [Abstract][Full Text] [Related]
8. Detection of minimal residual disease in acute myelogenous leukemia. Raanani P; Ben-Bassat I Acta Haematol; 2004; 112(1-2):40-54. PubMed ID: 15179004 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia. Cloos J; Harris JR; Janssen JJWM; Kelder A; Huang F; Sijm G; Vonk M; Snel AN; Scheick JR; Scholten WJ; Carbaat-Ham J; Veldhuizen D; Hanekamp D; Oussoren-Brockhoff YJM; Kaspers GJL; Schuurhuis GJ; Sasser AK; Ossenkoppele G J Vis Exp; 2018 Mar; (133):. PubMed ID: 29553571 [TBL] [Abstract][Full Text] [Related]
10. [Quantification of minimal residual disease by multiparameter flow cytometry in acute myeloid leukemia. From diagnosis to prognosis]. Kern W; Haferlach T Med Klin (Munich); 2005 Jan; 100(1):54-9. PubMed ID: 15654545 [TBL] [Abstract][Full Text] [Related]
12. Minimal/Measurable Residual Disease Monitoring in Forghieri F; Comoli P; Marasca R; Potenza L; Luppi M Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404199 [TBL] [Abstract][Full Text] [Related]
13. Morphology and classification of acute myeloid leukemias. Krause JR Clin Lab Med; 2000 Mar; 20(1):1-16. PubMed ID: 10702892 [TBL] [Abstract][Full Text] [Related]
14. Acute leukemia. Schumacher HR; Alvares CJ; Blough RI; Mazzella F Clin Lab Med; 2002 Mar; 22(1):153-92, vii. PubMed ID: 11933574 [TBL] [Abstract][Full Text] [Related]
15. [Diagnostics, classification and prognostic criteria of acute myeloid leukemia]. Heilmeier B; Buske C; Spiekermann K; Bohlander S; Feuring-Buske M; Hiddemann W; Braess J Med Klin (Munich); 2007 Apr; 102(4):296-308. PubMed ID: 17426933 [TBL] [Abstract][Full Text] [Related]
16. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies. Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517 [TBL] [Abstract][Full Text] [Related]
17. The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia. Al-Mawali A; Gillis D; Lewis I Am J Clin Pathol; 2009 Jan; 131(1):16-26. PubMed ID: 19095561 [TBL] [Abstract][Full Text] [Related]